BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8494233)

  • 1. Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey.
    Homburger HA; Rosenstock W; Paxton H; Paton ML; Landay AL
    Ann N Y Acad Sci; 1993 Mar; 677():43-9. PubMed ID: 8494233
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term monthly proficiency testing.
    Rickman WJ; Monical C; Waxdal MJ
    Ann N Y Acad Sci; 1993 Mar; 677():53-8. PubMed ID: 8494246
    [No Abstract]   [Full Text] [Related]  

  • 3. National external quality assessment scheme for lymphocyte immunophenotyping in Belgium.
    Van Blerk M; Bernier M; Bossuyt X; Chatelain B; D'Hautcourt JL; Demanet C; Kestens L; Van Bockstaele D; Crucitti T; Libeer JC
    Clin Chem Lab Med; 2003 Mar; 41(3):323-30. PubMed ID: 12705342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%.
    Gelman R; Wilkening C
    Cytometry; 2000 Feb; 42(1):1-4. PubMed ID: 10679736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.
    Bainbridge J; Wilkening CL; Rountree W; Louzao R; Wong J; Perza N; Garcia A; Denny TN
    J Immunol Methods; 2014 Jul; 409():82-90. PubMed ID: 24911327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis.
    Gratama JW; Kraan J; Adriaansen H; Hooibrink B; Levering W; Reinders P; Van den Beemd MW; Van der Holt B; Bolhuis RL
    Cytometry; 1997 Feb; 30(1):10-22. PubMed ID: 9056737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of lyophilized human cells as antigenic controls for flow cytometry measurements.
    Maples JA
    Ann N Y Acad Sci; 1993 Mar; 677():420-1. PubMed ID: 8494230
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of clinical standards for flow cytometry.
    Schwartz A; Fernández-Repollet E
    Ann N Y Acad Sci; 1993 Mar; 677():28-39. PubMed ID: 8388180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference intervals of CD3, CD4, CD8, CD4/CD8, and absolute CD4 values in Asian and Non-Asian populations.
    Howard RR; Fasano CS; Frey L; Miller CH
    Cytometry; 1996 Sep; 26(3):231-2. PubMed ID: 8889397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
    Nicholson JK
    Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program.
    Gelman R; Cheng SC; Kidd P; Waxdal M; Kagan J
    Clin Immunol Immunopathol; 1993 Feb; 66(2):150-62. PubMed ID: 7680972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control in flow cytometry for diagnostic pathology: II. A conspectus of reference ranges for lymphocyte immunophenotyping.
    McCoy JP; Overton WR
    Cytometry; 1994 Sep; 18(3):129-39. PubMed ID: 7813333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of variation in results of flow cytometric lymphocyte immunophenotyping in a multicenter study.
    Gratama JW; Kraan J; Van den Beemd R; Hooibrink B; Van Bockstaele DR; Hooijkaas H
    Cytometry; 1997 Aug; 30(4):166-77. PubMed ID: 9298834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy.
    Brando B; Sommaruga E
    Cytometry; 1993; 14(3):294-306. PubMed ID: 8472606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centers for Disease Control programs in flow cytometric immunophenotyping.
    Gerber AR
    Ann N Y Acad Sci; 1993 Mar; 677():40-2. PubMed ID: 8388182
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality control in immunophenotyping. Use of human CD4+ and CD8+ T clones as standards.
    Kunkl A; Valle MT; Fenoglio D; Manca F
    Ann N Y Acad Sci; 1993 Mar; 677():417-9. PubMed ID: 8494229
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of interlaboratory variability in analytical cytology. Results of the College of American Pathologists Flow Cytometry Study.
    Homburger HA; McCarthy R; Deodhar S
    Arch Pathol Lab Med; 1989 Jun; 113(6):667-72. PubMed ID: 2658910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory quality assessment of lymphocyte phenotyping. Etalonorme 1990-1992 surveys.
    Goguel AF; Crainic K; Ducailar A; Ouin M
    Biol Cell; 1993; 78(1-2):79-84. PubMed ID: 8220229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study Group.
    Landay AL; Brambilla D; Pitt J; Hillyer G; Golenbock D; Moye J; Landesman S; Kagan J
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):462-8. PubMed ID: 7583925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.